Alix Earle is adding another brand to her expanding investment portfolio. The 25-year-old influencer and soon-to-be reality TV star has taken a stake in liposomal supplement brand Cymbiotika, which has been on a cultural hot streak of late and reached $150 million in 2025 revenue. Cymbiotika’s liposomal supplements. CourtesyFounded in San Diego in 2019, Cymbiotika is known for its signature liposomal format, where supplements come in flavored, single-serving 5-ml. “In the case of Alix Earle, Cymbiotika sees a unique cultural catalyst who can drive awareness and education that naturally translates across every channel.”